Chinese Biotech Breakthroughs

Results

0 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

4 companies

Suzhou Zelgen Biopharmaceuticals

Market Cap: CN¥21.2b

Engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China.

688266

CN¥80.06

-15.2%

-4.1%

Dizal (Jiangsu) Pharmaceutical

Market Cap: CN¥22.9b

A biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of cancer and immunological diseases.

688192

CN¥49.21

-8.6%

3.6%

Shenzhen Kangtai Biological Products

Market Cap: CN¥16.1b

Shenzhen Kangtai Biological Products Co., Ltd.

300601

CN¥14.44

-2.8%

-5.6%

Nanjing Vazyme Biotech

Market Cap: CN¥8.1b

Offers technology solutions for life science, biomedicine, and in vitro diagnostics.

688105

CN¥20.33

-2.2%

-8.9%